Stoke Therapeutics had a revenue of 158.57M in the quarter ending Mar 31, 2025, with 601.20%. This bring the company's revenue in the last twelve months to 190.91M, Decreased 422.25%. In the fiscal year ending Dec 31, 2024, Stoke Therapeutics had annual revenue of 36.55M with 316.34% growth.